USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke ONCAIDIA wurde als Wortmarke am 03.03.2008 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 15.09.2009 im Markenregister eingetragen.
Der aktuelle Status der Marke ist "IR CANCELLED; US REGISTRATION CANCELLED".
| Markenform | Wortmarke |
| Aktenzeichen | 79060738 |
| Registernummer | 3683346 |
| Anmeldedatum | 03. März 2008 |
| Veröffentlichungsdatum | 30. Juni 2009 |
| Eintragungsdatum | 15. September 2009 |
Markeninhaber
NORTH ADELAIDE SA 5006
Markenvertreter
Waren und Dienstleistungen
5
Pharmaceutical products and preparations of antibodies, immunoreactive and/or antigen-binding fragments of antibodies, or direct modifications, conjugates or functionalized derivatives of antibodies, for health care, all the foregoing for the treatment of malignant, inflammatory andautoimmune disorders and conditions, tissue trauma and tissue ischaemia; pharmaceutical products and preparations of antibodies, immunoreactive and/or antigen-binding fragments of antibodies, or direct modifications, conjugates or functionalized derivatives of antibodies, for radio-immuno-diagnosis or radio-immuno-therapy, the foregoing for the diagnosis and treatment of malignant, inflammatory and autoimmune disorders and conditions, tissue trauma and tissue ischaemia; pharmaceutical preparations used in the therapy and diagnosis of malignant, inflammatory and autoimmune disorders and conditions, tissue trauma and tissue ischaemia; diagnostic preparations for detecting the presence of cancer in humans, the foregoing for medical use; anti-cancer preparations, namely, preparations consisting of monoclonal antibodies and fragments thereof for cancer research and pharmaceutical development, biomedical research, veterinary vaccines, veterinary diagnostic and treatment purposes, clinical trials for cancer pharmaceuticals, cancer diagnosis and cancer therapy purposes; anti-cancer preparations, namely, preparations consisting of cultures and preparations of hybridoma and other cells for medical, diagnostic and veterinary purposes; medicinal products of antibodies, immunoreactive and/or antigen-binding fragments of antibodies, or direct modifications, conjugates or functionalized derivatives of antibodies, the foregoing for the treatment of malignant, inflammatory and autoimmune disorders and conditions, tissue trauma and tissue ischaemia
42
Scientific and technological services and research and design relating thereto, namely, scientific research for medical purposes; development of medical products, namely, pharmaceutical drugs, delivery systems for pharmaceutical drugs and diagnostic and therapeutic products; advisory services relating to medical research
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1379060738